Skip to news
JQJO
Latest

Eli Lilly Lifts Outlook After Strong Quarter | JQJO

Eli Lilly Lifts Outlook After Strong Quarter

Eli Lilly Lifts Outlook After Strong Quarter

Tap title to read story

0:00 / 0:56

Eli Lilly posted third-quarter results that topped expectations and raised its outlook, sending shares up 5% premarket. Adjusted EPS reached $7.02 on revenue of $17.60 billion, beating estimates. The company now targets fiscal 2025 revenue of $63–$63.5 billion and full-year adjusted profit of $23–$23.70 per share. Demand for GLP-1 drugs powered the quarter: Mounjaro generated $6.52 billion, up 109% and above forecasts, while Zepbound brought in $3.57 billion, up 184% and slightly ahead of estimates. The strong showing comes as Lilly seeks to maintain its edge over Novo Nordisk in the booming obesity and diabetes market.

Published · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

More context

Sources

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

Putin Criticizes EU at APEC Summit

Tap title to read story

0:00 / 0:44

MLB Lockout Threatens 2027 Season

Tap title to read story

0:00 / 0:35

Bedard Injured, Blackhawks Win 6-3

Tap title to read story

0:00 / 0:37

PS5 Update Needed for GTA 6

Tap title to read story

0:00 / 0:41

JQJO

Find your next story

Search JQJO’s current coverage.